z-logo
open-access-imgOpen Access
MOYAMOYA DISEASE PRESENTING AS ACUTE ENCEPHALITIS SYNDROME
Author(s) -
Harshal Pamecha,
Bhavana Saraf
Publication year - 2020
Publication title -
global journal for research analysis
Language(s) - English
DOI - 10.36106/gjra/8311089
Subject(s) - medicine , circle of willis , moyamoya disease , asymptomatic , surgery , meningoencephalitis , radiology , pregnancy , occlusion , pathology , biology , genetics
Background: Moyamoya disease (MMD) is a chronic, progressive occlusion of the circle of Willis arteries usually affects bilateral carotid arteries than unilateral that leads to the development of characteristic collateral vessels seen on imaging, particularly cerebral angiography. Once the occlusion process begins, tends to continue despite any known medical management unless treated with revascularization surgeryReport of the case: A 28 year female gravida four in 34th week of gestation presented with features suggestive of acute meningoencephalitis and CSF examination suggested 75% polymorphs of 300 total leukocytes. After 7 days of optimum management, complaints of headache aggravated so patient was subjected to MRI Brain which reported as early subacute intraparenchymal haemorrhage left frontal lobe in periventricular region with mild surrounding perifocal edema and intraventricular extension. On further MR angiogram, patient was diagnosed as MMD. Patient was asymptomatic in her previous 3 pregnancies and presently underwent planned preterm high risk caesarean section after a week. However condition of patient deteriorated over 2 weeks post delivery, did not remain fit for any neurosurgical intervention and unfortunately succumbed to death.Conclusion: Antenatal patient presenting as acute meningoencephalitis with persistent headache refractory to medical therapy, should be subjected to CT/MR brain imaging for rare possibility of MMD and early neurosurgical interventions in view of its grave prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here